Inflammasome-associated nucleotide-binding domain, leucine-rich repeat proteins and inflammatory diseases

Journal of Immunology

Volumn 183, Issue 12, 2009, Pages 7623-7629

  Jha, Sushmita ^a   Ting, Jenny P Y ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN 7; CDP 484; CJ 14877; CJ 14897; CP 412245; CP 424174; CRYOPYRIN; INFLAMMASOME; LACTONE DERIVATIVE; LL Z 1217 A; NEURONAL APOPTOSIS INHIBITORY PROTEIN; NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT 4; NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT PROTEIN; PEPTIDOMIMETIC AGENT; PRALNACASAN; PROTEIN SERINE THREONINE KINASE; PYRIDINE DERIVATIVE; RECOMBINANT ANTIBODY; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ST 2825; UNCLASSIFIED DRUG; UREA DERIVATIVE; VX 765; AUTACOID; LEUCINE RICH REPEAT PROTEINS; LEUCINE-RICH REPEAT PROTEINS; NUCLEOTIDE; PROTEIN;

ASBESTOSIS; CINCA SYNDROME; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; GENE MUTATION; GOUT; HUMAN; IMMUNOPATHOLOGY; INFLAMMATORY DISEASE; INNATE IMMUNITY; MISSENSE MUTATION; MUCKLE WELLS SYNDROME; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PSEUDOGOUT; REVIEW; SILICOSIS; VITILIGO; AMINO ACID SEQUENCE; ANIMAL; DRUG DELIVERY SYSTEM; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; NUCLEOTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; REPETITIVE SEQUENCES, AMINO ACID;

EID: 76249102596     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902425     Document Type: Review

References (78)

1. Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27: 229-265.
2. Ogura, Y., F. S. Sutterwala, and R. A. Flavell. 2006. The inflammasome: first line of the immune response to cell stress. Cell 126: 659-662. (Pubitemid 44233635)
3. Ting, J. P., and B. K. Davis. 2005. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol. 23: 387-414.
4. Ting, J. P., D. L. Kastner, and H. M. Hoffman. 2006. CATERPILLERs, pyrin and hereditary immunological disorders. Nat. Rev. Immunol. 6: 183-195.
5. Amer, A., L. Franchi, T. D. Kanneganti, M. Body-Malapel, N. Ozoren, G. Brady, S. Meshinchi, R. Jagirdar, A. Gewirtz, S. Akira, and G. Nunez. 2006. Regulation of Legionella phagosome maturation and infection through flagellin and host Ipaf. J. Biol. Chem. 281: 35217-35223. (Pubitemid 46043249)
6. Franchi, L., A. Amer, M. Body-Malapel, T. D. Kanneganti, N. Ozoren, R. Jagirdar, N. Inohara, P. Vandenabeele, J. Bertin, A. Coyle, et al. 2006. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in salmonella-infected macrophages. Nat. Immunol. 7: 576-582. (Pubitemid 43797338)
7. Miao, E. A., C. M. Alpuche-Aranda, M. Dors, A. E. Clark, M. W. Bader, S. I. Miller, and A. Aderem. 2006. Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nat. Immunol. 7: 569-575.
8. Miao, E. A., R. K. Ernst, M. Dors, D. P. Mao, and A. Aderem. 2008. Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc. Nat. Acad. Sci. USA 105: 2562-2567.
9. Suzuki, T., L. Franchi, C. Toma, H. Ashida, M. Ogawa, Y. Yoshikawa, H. Mimuro, N. Inohara, C. Sasakawa, and G. Nunez. 2007. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathog. 3: e111.
10. Lightfield, K. L., J. Persson, S. W. Brubaker, C. E. Witte, J. von Moltke, E. A. Dunipace, T. Henry, Y. H. Sun, D. Cado, W. F. Dietrich, et al. 2008. Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat. Immunol. 9: 1171-1178.
11. Sutterwala, F. S., L. A. Mijares, L. Li, Y. Ogura, B. I. Kazmierczak, and R. A. Flavell. 2007. Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J. Exp. Med. 204: 3235-3245.
12. Kanneganti, T. D., M. Body-Malapel, A. Amer, J. H. Park, J. Whitfield, L. Franchi, Z. F. Taraporewala, D. Miller, J. T. Patton, N. Inohara, and G. Nunez. 2006. Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA. J. Biol. Chem. 281: 36560-36568.
13. Kanneganti, T. D., N. Ozoren, M. Body-Malapel, A. Amer, J. H. Park, L. Franchi, J. Whitfield, W. Barchet, M. Colonna, P. Vandenabeele, et al. 2006. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440: 233-236.
14. Di Paolo, N. C., E. A. Miao, Y. Iwakura, K. Murali-Krishna, A. Aderem, R. A. Flavell, T. Papayannopoulou, and D. M. Shayakhmetov. 2009. Virus binding to a plasma membrane receptor triggers interleukin-1 α-mediated proinflammatory macrophage response in vivo. Immunity 31: 110-121.
15. Muruve, D. A., V. Petrilli, A. K. Zaiss, L. R. White, S. A. Clark, P. J. Ross, R. J. Parks, and J. Tschopp. 2008. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452: 103-107.
16. Lamkanfi, M., R. K. Malireddi, and T. D. Kanneganti. 2009. Fungal zymosan and mannan activate the cryopyrin inflammasome. J. Biol. Chem. 284: 20574-20581.
17. Mariathasan, S., D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, and V. M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.
18. Martinon, F., V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241. (Pubitemid 43372104)
19. Shi, Y., J. E. Evans, and K. L. Rock. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521. (Pubitemid 37237047)
20. Halle, A., V. Hornung, G. C. Petzold, C. R. Stewart, B. G. Monks, T. Reinheckel, K. A. Fitzgerald, E. Latz, K. J. Moore, and D. T. Golenbock. 2008. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat. Immunol. 9: 857-865.
21. Dostert, C., V. Petrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677. (Pubitemid 351928351)
22. Perkins, R. C., R. K. Scheule, R. Hamilton, G. Gomes, G. Freidman, and A. Holian. 1993. Human alveolar macrophage cytokine release in response to in vitro and in vivo asbestos exposure. Exp. Lung Res. 19: 55-65.
23. Scheibner, K. A., M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton. 2006. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177: 1272-1281.
24. Zou, H., Y. Li, X. Liu, and X. Wang. 1999. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 274: 11549-11556. (Pubitemid 29197809)
25. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827. (Pubitemid 26193033)
26. Shao, W., G. Yeretssian, K. Doiron, S. N. Hussain, and M. Saleh. 2007. The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J. Biol. Chem. 282: 36321-36329.
27. Keller, M., A. Ruegg, S. Werner, and H. D. Beer. 2008. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132: 818-831. (Pubitemid 351312798)
28. Sutterwala, F. S., Y. Ogura, M. Szczepanik, M. Lara-Tejero, G. S. Lichtenberger, E. P. Grant, J. Bertin, A. J. Coyle, J. E. Galan, P. W. Askenase, and R. A. Flavell. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24: 317-327.
29. Duncan, J. A., X. Gao, M. T. Huang, B. P. O'Connor, C. E. Thomas, S. B. Willingham, D. T. Bergstralh, G. A. Jarvis, P. F. Sparling, and J. P. Ting. 2009. Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasome. J. Immunol. 182: 6460-6469.
30. Marina-Garcia, N., L. Franchi, Y. G. Kim, D. Miller, C. McDonald, G. J. Boons, and G. Nunez. 2008. Pannexin-1-mediated intracellular delivery of muramyl dipeptide induces caspase-1 activation via cryopyrin/NLRP3 independently of Nod2. J. Immunol. 180: 4050-4057.
31. Yamasaki, K., J. Muto, K. R. Taylor, A. L. Cogen, D. Audish, J. Bertin, E. P. Grant, A. J. Coyle, A. Misaghi, H. M. Hoffman, and R. L. Gallo. 2009. NLRP3/Cryopyrin is necessary for interleukin-1β (IL-1β) release in response to Hyaluronan, an endogenous trigger of inflammation in response to injury. J. Biol. Chem. 284: 12762-12771.
32. Hornung, V., F. Bauernfeind, A. Halle, E. O. Samstad, H. Kono, K. L. Rock, K. A. Fitzgerald, and E. Latz. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9: 847-856.
33. Li, H., S. B. Willingham, J. P. Ting, and F. Re. 2008. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181: 17-21.
34. Mariathasan, S., K. Newton, D. M. Monack, D. Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson, and V. M. Dixit. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218.
35. Li, P., H. Allen, S. Banerjee, and T. Seshadri. 1997. Characterization of mice deficient in interleukin-1β converting enzyme. J. Cell. Biochem. 64: 27-32. (Pubitemid 27081792)
36. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10: 417-426. (Pubitemid 35007355)
37. Ting, J. P., R. C. Lovering, E. S. Alnemri, J. Bertin, J. M. Boss, B. K. Davis, R. A. Flavell, S. E. Girardin, A. Godzik, J. A. Harton, et al. 2008. The NLR gene family: a standard nomenclature. Immunity 28: 285-287.
38. Chu, Z. L., F. Pio, Z. Xie, K. Welsh, M. Krajewska, S. Krajewski, A. Godzik, and J. C. Reed. 2001. A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J. Biol. Chem. 276: 9239-9245.
39. Hlaing, T., R. F. Guo, K. A. Dilley, J. M. Loussia, T. A. Morrish, M. M. Shi, C. Vincenz, and P. A. Ward. 2001. Molecular cloning and characterization of DEFCAP- L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J. Biol. Chem. 276: 9230-9238. (Pubitemid 37385506)
40. Faustin, B., L. Lartigue, J. M. Bruey, F. Luciano, E. Sergienko, B. Bailly-Maitre, N. Volkmann, D. Hanein, I. Rouiller, and J. C. Reed. 2007. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25: 713-724.
41. Hsu, L. C., S. R. Ali, S. McGillivray, P. H. Tseng, S. Mariathasan, E. W. Humke, L. Eckmann, J. J. Powell, V. Nizet, V. M. Dixit, and M. Karin. 2008. A NOD2-NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide. Proc. Natl. Acad. Sci. USA 105: 7803-7808.
42. Geddes, B. J., L. Wang, W. J. Huang, M. Lavellee, G. A. Manji, M. Brown, M. Jurman, J. Cao, J. Morgenstern, S. Merriam, et al. 2001. Human CARD12 is a novel CED4/Apaf-1 family member that induces apoptosis. Biochem. Biophys. Res. Commun. 284: 77-82.
43. Poyet, J. L., S. M. Srinivasula, M. Tnani, M. Razmara, T. Fernandes-Alnemri, and E. S. Alnemri. 2001. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 276: 28309-28313. (Pubitemid 37391538)
44. Endrizzi, M. G., V. Hadinoto, J. D. Growney, W. Miller, and W. F. Dietrich. 2000. Genomic sequence analysis of the mouse Naip gene array. Genome Res. 10: 1095-1102.
45. Zamboni, D. S., K. S. Kobayashi, T. Kohlsdorf, Y. Ogura, E. M. Long, R. E. Vance, K. Kuida, S. Mariathasan, V. M. Dixit, R. A. Flavell, et al. 2006. The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat. Immunol. 7: 318-325.
46. Masters, S. L., A. A. Lobito, J. Chae, and D. L. Kastner. 2006. Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr. Opin. Allergy Clin. Immunol. 6: 428-433.
47. Ryan, J. G., and D. L. Kastner. 2008. Fevers, genes, and innate immunity. Curr. Top. Microbiol. Immunol. 321: 169-184.
48. Boschan, C., O. Witt, P. Lohse, I. Foeldvari, H. Zappel, and L. Schweigerer. 2006. Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment. Am J. Med. Genet. A 140: 883-886.
49. Lequerre, T., O. Vittecoq, P. Saugier-Veber, A. Goldenberg, P. Patoz, T. Frebourg, and X. L. Loet. 2006. A cryopyrin-associated periodic syndrome with joint destruction. Rheumatology (Oxford) 46: 709-714. (Pubitemid 46523322)
50. Kone-Paut, I., E. Sanchez, A. Le Quellec, R. Manna, and I. Touitou. 2007. Autoinflammatory gene mutations in Behcet's disease. Ann. Rheum. Dis. 66: 832-824. (Pubitemid 46846709)
51. Neven, B., I. Callebaut, A. M. Prieur, J. Feldmann, C. Bodemer, L. Lepore, B. Derfalvi, S. Benjaponpitak, R. Vesely, M. J. Sauvain, et al. 2004. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 103: 2809-2815.
52. Agostini, L., F. Martinon, K. Burns, M. F. McDermott, P. N. Hawkins, and J. Tschopp. 2004. NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325. (Pubitemid 38388233)
53. Gattorno, M., S. Tassi, S. Carta, L. Delfino, F. Ferlito, M. A. Pelagatti, A. D'Osualdo, A. Buoncompagni, M. G. Alpigiani, M. Alessio, et al. 2007. Pattern of interleukin-1β secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum. 56: 3138-3148. (Pubitemid 47502762)
54. Dode, C., N. Le Du, L. Cuisset, F. Letourneur, J. M. Berthelot, G. Vaudour, A. Meyrier, R. A. Watts, D. G. Scott, A. Nicholls, et al. 2002. New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am. J. Hum. Genet. 70: 1498-1506.
55. Aksentijevich, I., M. Nowak, M. Mallah, J. J. Chae, W. T. Watford, S. R. Hofmann, L. Stein, R. Russo, D. Goldsmith, P. Dent, et al. 2002. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatalonset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 46: 3340-3348.
56. Hoffman, H. M., S. G. Gregory, J. L. Mueller, M. Tresierras, D. H. Broide, A. A. Wanderer, and R. D. Kolodner. 2003. Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P. Human Genet. 112: 209-216.
57. Hoffman, H. M., J. L. Mueller, D. H. Broide, A. A. Wanderer, and R. D. Kolodner. 2001. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29: 301-305.
58. Feldmann, J., A. M. Prieur, P. Quartier, P. Berquin, S. Certain, E. Cortis, D. Teillac-Hamel, A. Fischer, and G. de Saint Basile. 2002. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet. 71: 198-203. (Pubitemid 34734724)
59. Manji, G. A., L. Wang, B. J. Geddes, M. Brown, S. Merriam, A. Al-Garawi, S. Mak, J. M. Lora, M. Briskin, M. Jurman, et al. 2002. PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-κB. J. Biol. Chem. 277: 11570-11575.
60. Milhavet, F., L. Cuisset, H. M. Hoffman, R. Slim, H. El-Shanti, I. Aksentijevich, S. Lesage, H. Waterham, C. Wise, C. Sarrauste de Menthiere, and I. Touitou. 2008. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum. Mut. 29: 803-808. (Pubitemid 351794131)
61. Brydges, S. D., J. L. Mueller, M. D. McGeough, C. A. Pena, A. Misaghi, C. Gandhi, C. D. Putnam, D. L. Boyle, G. S. Firestein, A. A. Horner, et al. 2009. Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 30: 875-887.
62. Meng, G., F. Zhang, I. Fuss, A. Kitani, and W. Strober. 2009. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 30: 860-874.
63. Jin, Y., C. M. Mailloux, K. Gowan, S. L. Riccardi, G. LaBerge, D. C. Bennett, P. R. Fain, and R. A. Spritz. 2007. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356: 1216-1225. (Pubitemid 46465597)
64. Chen, C. J., Y. Shi, A. Hearn, K. Fitzgerald, D. Golenbock, G. Reed, S. Akira, and K. L. Rock. 2006. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116: 2262-2271.
65. Gasse, P., N. Riteau, S. Charron, S. Girre, L. Fick, V. Petrilli, J. Tschopp, V. Lagente, V. F. Quesniaux, B. Ryffel, and I. Couillin. 2009. Uric acid is a danger signal activating NALP3 inflammasome in lung injury inflammation and fibrosis. Am. J. Respir. Crit. Care Med. 179: 903-913.
66. Jeru, I., P. Duquesnoy, T. Fernandes-Alnemri, E. Cochet, J. W. Yu, M. Lackmy-Port-Lis, E. Grimprel, J. Landman-Parker, V. Hentgen, S. Marlin, et al. 2008. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc. Natl. Acad. Sci. USA 105: 1614-1619. (Pubitemid 351346563)
67. Lich, J. D., K. L. Williams, C. B. Moore, J. C. Arthur, B. K. Davis, D. J. Taxman, and J. P. Ting. 2007. Monarch-1 suppresses non-canonical NF-κB activation and p52-dependent chemokine expression in monocytes. J. Immunol. 178: 1256-1260.
68. Williams, K. L., J. D. Lich, J. A. Duncan, W. Reed, P. Rallabhandi, C. Moore, S. Kurtz, V. M. Coffield, M. A. Accavitti-Loper, L. Su, et al. 2005. The CATERPILLER protein Monarch-1 is an antagonist of Toll-like receptor-, tumor necrosis factor α-, and Mycobacterium tuberculosis-induced pro-inflammatory signals. J. Biol. Chem. 280: 39914-39924.
69. Dinarello, C. A. 2009. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 27: 519-550.
70. Braddock, M., and A. Quinn. 2004. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat. Rev. Drug Discov. 3: 330-339. (Pubitemid 38499760)
71. Ichikawa, K., H. Hirai, M. Ishiguro, T. Kambara, Y. Kato, Y. J. Kim, Y. Kojima, Y. Matsunaga, H. Nishida, Y. Shiomi, et al. 2001. Cytokine production inhibitors produced by a fungus, Oidiodendron griseum. J. Antibiot. 54: 697-702. (Pubitemid 32962794)
72. Hoffman, H. M. 2009. Rilonacept for the treatment of cryopyrin-associated periodic syndromes (CAPS). Expert Opin. Biol. Ther. 9: 519-531.
73. Bartfai, T., M. M. Behrens, S. Gaidarova, J. Pemberton, A. Shivanyuk, and J. Rebek, Jr. 2003. A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses. Proc. Natl. Acad. Sci. USA 100: 7971-7976. (Pubitemid 36760079)
74. Loiarro, M., F. Capolunghi, N. Fanto, G. Gallo, S. Campo, B. Arseni, R. Carsetti, P. Carminati, R. De Santis, V. Ruggiero, and C. Sette. 2007. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. J. Leukocyte Biol. 82: 801-810. (Pubitemid 47511039)
75. Loiarro, M., C. Sette, G. Gallo, A. Ciacci, N. Fanto, D. Mastroianni, P. Carminati, and V. Ruggiero. 2005. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-κB. J. Biol. Chem. 280: 15809-15814. (Pubitemid 40616701)
76. Buckley, G. M., L. Gowers, A. P. Higueruelo, K. Jenkins, S. R. Mack, T. Morgan, D. M. Parry, W. R. Pitt, O. Rausch, M. D. Richard, et al. 2008. IRAK-4 inhibitors. Part 1: a series of amides. Bioorg. Med. Chem. Lett. 18: 3211-3214.
77. Buckley, G. M., R. Fosbeary, J. L. Fraser, L. Gowers, A. P. Higueruelo, L. A. James, K. Jenkins, S. R. Mack, T. Morgan, D. M. Parry, et al. 2008. IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridines. Bioorg. Med. Chem. Lett. 18: 3656-3660.
78. Buckley, G. M., T. A. Ceska, J. L. Fraser, L. Gowers, C. R. Groom, A. P. Higueruelo, K. Jenkins, S. R. Mack, T. Morgan, D. M. Parry, et al. 2008. IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding. Bioorg. Med. Chem. Lett. 18: 3291-3295.